Detectability of Plasma-Derived Circulating Tumor DNA Panel in Patients Undergoing Primary Treatment for Uveal Melanoma.
Invest Ophthalmol Vis Sci
; 63(13): 17, 2022 12 01.
Article
in En
| MEDLINE
| ID: mdl-36525262
Full text:
1
Collection:
01-internacional
Database:
MEDLINE
Main subject:
Uveal Neoplasms
/
Circulating Tumor DNA
/
Melanoma
Limits:
Humans
Language:
En
Journal:
Invest Ophthalmol Vis Sci
Year:
2022
Document type:
Article
Affiliation country:
Country of publication: